Global Health Dialogues with Her Royal Highness Princess Dina Mired features Professor Gevorg Tamamyan, MD, PhD, pediatric oncologist, global health expert, and Chief Executive Officer of the Immune Oncology Research Institute (IMMONC).
In this episode, Professor Tamamyan discusses the development and system-level transformation of pediatric oncology services in Armenia, and the broader implications for childhood cancer care models in low- and middle-income countries (LMICs). The conversation focuses on evidence-based strategies for building sustainable oncology systems, including service organization, workforce capacity building, and international institutional partnerships.
Key scientific and policy-relevant topics addressed include:
- Design and implementation of high-quality pediatric oncology programs in resource-constrained settings
- Leadership models for health system strengthening in oncology
- Development of complex clinical services, including hematopoietic stem cell transplantation
- Integration of clinical research, registries, and health data systems into national cancer programs
- Capacity building through medical education, mentorship, and professional training
- International collaboration and governance in global pediatric oncology
- Strategies to improve equity in access to cancer diagnosis and treatment
- Role of civil society and non-governmental organizations, including the City of Smile Foundation, in health service delivery
- Knowledge translation and scientific communication via OncoDaily
Professor Tamamyan also outlines his academic and advisory activities within Yerevan State Medical University, the International Society of Pediatric Oncology (SIOP), and multiple international working groups contributing to the WHO Global Initiative for Childhood Cancer and related global frameworks.
The episode provides a structured overview of practical health system interventions, leadership frameworks, and translational strategies relevant to clinicians, researchers, policymakers, and global health stakeholders involved in childhood cancer control.
To view the full episode click here.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048